5415-98-5

Usage

Uses

Used in Chemical Synthesis:
N,N-DiMethyl-2-Methylene-β-alanine is used as a building block in the synthesis of various organic compounds, particularly those with specific lipo/hydrophilic properties. Its unique structure allows for the creation of novel molecules with tailored characteristics, making it a valuable component in chemical research and development.
Used in Pyrimidine-based pH-sensitive Spin Probes:
N,N-DiMethyl-2-Methylene-β-alanine is used as a key component in the synthesis of pyrimidine-based pH-sensitive spin probes. These probes are essential tools in biochemistry and molecular biology for studying the pH levels and dynamics within cellular environments. N,N-DiMethyl-2-Methylene-β-alanine's structural properties enable the development of spin probes with diverse lipo/hydrophilic characteristics, which can be tailored to specific research applications and cellular targets.

InChI:InChI=1/C6H11NO2/c1-5(6(8)9)4-7(2)3/h1,4H2,2-3H3,(H,8,9)

Upstream product

• 50-00-0 formaldehyd 
• 141-82-2 malonic acid 
• 124-40-3 dimethyl amine 
• 1184-78-7 trimethylamine-N-oxide 
• 108-24-7 acetic anhydride 

Downstream Products

• 1092365-06-4 1-(3-(4-(3-chloro-2,4-difluorophenylamino)-7-methoxyquinazolin-6-yloxy)azetidin-1-yl)-2-((dimethylamino)methyl)prop-2-en-1-one 
• 1328624-15-2 N-((2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)pyrimidin-5-yl)oxazol-4-yl)methyl)-2-dimethylaminomethylacrylamide 
• 1328623-76-2 N-((2-(4-amino-6-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)pyrimidin-5-yl)oxazol-4-yl)methyl)-2-(dimethylaminomethyl)acrylamide 

Relevant academic research and scientific papers

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

The invention provides compounds of formula (I) or a pharmaceutically-acceptable salt thereof, wherein the variables are defined in the specification, that are inhibitors of JAK kinases, particularly JAK3. The invention also provides crystalline forms, ph

NOVEL PYRIMIDINE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS

The present invention provides a novel pyrimidine derivative or pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, which can effectively inhibit the growth of cancer cells induced by the overexpression of EGFR incl

NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS

The present invention provides a novel amide derivative and a pharmaceutically acceptable salt thereof which selectively and effectively inhibits the growth of cancer cells induced by the overexpression of an epidermal growth factor receptor and also prevents the development of drug resistance caused by the mutation of EGFR tyrosine kinase, and a pharmaceutical composition comprising same as an active ingredient.

3-Pyrazolidinone derivatives

3-Pyrazolidinone compounds having a solubility of at least 12 grams/liter in an aqueous medium of pH 9 of the formula: STR1 wherein R is a mononuclear phenyl group having substituents in the 3, 4, or 5 positions with a total of no more than 4 non-metallic